Incyte (Nasdaq: INCY) entered into a clinical trial agreement with Genentech (OTCBB RHHBY) to evaluate the safety, tolerability and preliminary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE